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ABSTRACT
Switching from a replicative to a translesion poly-
merase is an important step to further continue on
replication at the site of DNA lesion. Recently, RAD18
(a ubiquitin ligase) was shown to monoubiquitinate
proliferating cell nuclear antigen (PCNA) in coopera-
tion with RAD6 (a ubiquitin-conjugating enzyme) at
the replication-stalled sites, causing the polymerase
switch. Analyzing RAD18-knockout (RAD18 / )c e l l s
generated from human HCT116 cells, in addition to
the polymerase switch, we found a new function of
RAD18 for S phase-specific DNA single-strand break
repair (SSBR). Unlike the case with polymerase
switching, PCNA monoubiquitination was not neces-
sary for the SSBR. When compared with wild-type
HCT116 cells, RAD18 /  cells, defective in the repair
of X-ray-induced chromosomal aberrations, were
significantly hypersensitive to X-ray-irradiation and
also to the topoisomerase I inhibitor camptothecin
(CPT) capable of inducing single-strand breaks but
were not so sensitive to the topoisomerase II
inhibitor etoposide capable of inducing double-
strand breaks. However, such hypersensitivity to
CPT observed with RAD18 /  cells was limited to
only the S phase due to the absence of the RAD18 S
phase-specific function. Furthermore, the defective
SSBR observed in S phase of RAD18 /  cells was
also demonstrated by alkaline comet assay.
INTRODUCTION
Various types of DNA lesions generated by endogenous and
environmental factors in living organisms can be repaired by
various repair mechanisms (1). However, if a lesion is not yet
removed because of a limited repair capacity of cells and if
the DNA replication machinery encounters this lesion before
repair, then the replication machinery stalls at this lesion,
causing a gap in the newly synthesized strand opposite to
the damaged site. Further the gap could cause a secondary
damage, much severer than the ﬁrst one, such as DNA
double-strand break (DSB), and thus could cause cell death
unless the gap is ﬁlled. This gap ﬁlling is called as postrepli-
cation repair (PRR) and such gap ﬁlling function is conserved
from bacteria through to human cells (2,3).
In the budding yeast Saccharomyces cerevisiae, genes
belonging to the RAD6 epistasis group are involved in the
PRR pathway (4). Among these genes, those encoding
Rad6 (a ubiquitin-conjugating enzyme, E2) and Rad18
(a ubiquitin ligase, E3) play crucial roles in this pathway
(5,6). Yeast Rad18 was shown to bind to single-stranded
DNA and also to form a tight complex with Rad6 (5,7)
whereas Rad6 does not have any DNA-binding activity.
Thus it was proposed that such Rad18 bound to the gap
regions would recruit Rad6 to the replication-stalled sites,
where Rad6 modulates the function of a stalled DNA replica-
tion machinery with its ubiquitin-conjugating activity (5).
Recently, in yeast cells, the proliferating cell nuclear antigen
(PCNA), a DNA polymerase sliding clamp involved in
DNA replication and repair, was shown to be monoubiquiti-
nated at the lysine-164 site in a Rad18/Rad6-dependent
manner, which was necessary for carrying out translesion
synthesis (TLS) by Rad30, a yeast homolog of polymerase
h (poly h), which is a member of the RAD6 epistasis
group (8–11). Similarly, monoubiquitination of human and
mouse PCNAs was observed in a RAD18/RAD6-dependent
manner at the sites of replication forks stalled by ultraviolet
(UV) light-induced lesions, and caused a polymerase switch
from a replicative to a translesion polymerase, pol h
(12,13). Thus, the mechanism of polymerase switching
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The mutation of either RAD18 or RAD6 gene in yeast cells
resulted in hypersensitivity to various DNA-damaging agents
including UV light and methylmethanesulfonate (MMS) (14),
and caused the attenuation of the mutation-inducing ability
following such exposure (15). In mammals, only a single
homolog of yeast RAD18 has been identiﬁed (16). The
human and mouse RAD18 proteins can interact with two
forms of homologs of yeast Rad6, RAD6A and RAD6B,
both in vitro and in vivo (16–18). Either overexpression of
a dominant-negative RAD18 mutant protein in human cells
or targeted disruption of RAD18 in mouse embryonic stem
cells resulted in an increased sensitivity to various DNA-
damaging agents and also enhanced the genomic instability
as determined by increases in sister-chromatic exchange
(SCE) and also by stable transformation (16,17). These
phenotypes were also observed in the RAD18-knockout
chicken DT40 cells (19).
In the present study, to understand the role of RAD18
in human cells, we have generated RAD18-knockout
(RAD18 / ) cells from wild-type human HCT116 cells,
and investigated how RAD18 was involved in the repair
mechanism of DNA DSB or single-strand break (SSB) in
human cells inducing DSBs and SSBs by X-ray irradiation
and also with topoisomerase inhibitors in RAD18 /  cells.
As described above, RAD18 has been shown to function at
the polymerase switching for TLS through PCNA monoubiq-
uitination. Analyzing RAD18 /  cells, in addition to the
function of TLS, we found a new function of RAD18 in
DNA strand break repair.
We have observed that RAD18 /  cells, defective in the
repair of X-ray-induced chromosomal aberrations, were
signiﬁcantly hypersensitive to X-ray irradiation and also to
the topoisomerase I inhibitor camptothecin (CPT) capable
of inducing SSBs but were not so sensitive to the topoiso-
merase II inhibitor etoposide capable of inducing DSBs
as compared with parental HCT116 cells. Furthermore,
PCNA was not monoubiquitinated after X-ray irradiation
or treatment with topoisomerase I or II inhibitor even in the
parental HCT116 cells. Our experiments showed that
RAD18 /  cells were defective in SSB repair (SSBR), but
functional for DSB repair (DSBR). Further, it turned out
that, for SSBR, RAD18 /  cells were only defective in
S phase but not in non-S phase or in non-replicating state,
implying that RAD18 could have some unknown intriguing
function particularly in S phase, exerting such tolerance to
X-ray-induced or drug-induced SSBs, without PCNA
monoubiquitination.
MATERIALS AND METHODS
Cell lines and culture conditions
The human colon carcinoma cell line HCT116, which was
normal in p53 status but defective in mismatch repair gene
hMLH1, and its RAD18 /  derivative were cultured in
DMEM supplemented with 10% fetal bovine serum, 50 U/ml
penicillin G and 50 mg/ml streptomycin in a humidiﬁed 5%
CO2 incubator at 37 C.
Inactivation of RAD18 locus in HCT116
A promoterless neomycin resistance gene or poly(A)-
signalless puromycin resistance gene was inserted into exon2
of RAD18 in frame. A 4.1 kb 50-targeting element was ampli-
ﬁed from the isogenic DNA of HCT116 cells using the primer
set 50-GGTGTCGACAGGTTGGCAGTCTTATGGCACCA-
GCT-30 and 50-AATTCGCGGCCGCAGCAAATCATCTAT-
TGTCTGAAATGC-30. A 3.3 kb 30-targeting element was
ampliﬁed using the primer set 50-ACATTGCGGCCGCAA-
TACCTCAGTGTTCACATAACTG-30 and 50-CAAAAGGC-
GCGCCTGATGGCTTACAGCAACTCTGGAGA-30.A m p l i -
ﬁed PCR products were cloned into a modiﬁed pBC vector
(Stratagene). Both neomycin and puromycin resistance cas-
settes were prepared from pIRESneo2 and pIRESpuro2
(Clontech), respectively. Targeting vectors linearized with
AscI were introduced into cells as described previously
(20). For the selection of targeted cells, G418 and puromycin
were added at 350 and 0.35 mg/ml, respectively. After
14 days, colonies were isolated and expanded. Genomic
DNA from individual colonies was screened for gene target-
ing by PCR using the primer sets 50-TGGCAGTCAT-
GAAGGTGAGTGCTTCG-30 and 50-ATTTTCCACCATGA-
TATTCGGCAAGCAGGC-30 for neomycin resistance, and
50-AGGCGCACCGTGGGCTTGTACTCGGTCATG-30 and
50-CTTGTCGACACGCGTCCAGCTGGTTCTTTCCGCCT-
C-30 for puromycin resistance. To conﬁrm the gene targeting,
genomic DNA from candidate clones was digested with SpeI
and KpnI and was subjected to Southern blot analysis. The
blots were hybridized with an external probe, a 30-region of
the targeting constructs as described previously (21).
Western blotting
Cell extracts were electrophoresed in 10% SDS–PAGE gels.
Following transfer on to PVDF ﬁlters, the blots were probed
with a mouse anti-PCNA antibody (PC10; Santa Cruz Bio-
technology), an anti-RAD18 antibody raised in rabbits (16)
or an anti-FLAG antibody (M2; Sigma).
Synchronization
Cells were synchronized by the thymidine-hydroxyurea block
method. Brieﬂy, 5 · 10
4 cells were seeded to 3.5 cm dishes
and grown for 2 days. Thymidine was then added to a ﬁnal
concentration of 1.5 mM and cells were further incubated
for 23–24 h. The cells were released from thymidine block
by washing three times with the medium. After a 10 h incuba-
tion in the fresh medium, HU was added to a ﬁnal concentra-
tion of 1 mM and cells were incubated for 15–16 h. Under
these conditions, the cells were accumulated at the G1/S
boundary. HU was removed by washing three times with
the fresh medium. The cells were incubated for 1 or 5 h in
the fresh medium to obtain cells at early S phase or late
S/G2 phase, respectively. The synchronization of the cell
cycle was conﬁrmed using FACSCalibur (Becton Dickinson).
Growth rates and cell survival assays
Cells were plated at a density of 2 · 10
4 cells per 35 mm dish
and cultured at 37 C.
On the days indicated, cells were counted using a hemato-
cytometer. All measurements were performed in triplicate.
Cell survival assay was carried out as follows. Cells were
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2 or 10
3 cells per 60 mm dish and
irradiated with X-ray or UV light, or cultured in the medium
containing indicated doses of cisplatin, MMS, etoposide
(VP-16) or CPT. In some experiments, synchronized or ran-
domly growing cells were treated with indicated concentra-
tions of CPT for 2 h. For aphidicolin (APH) experiments,
APH (1 mg/ml) was added 15 min before CPT was added.
The exponentially growing cells were incubated with the
two drugs together for 2 h. After treatment, cells were washed
twice with the culture medium, followed by a 2 h incubation
in the medium containing 1 mg/ml APH. Then, the cells were
washed twice with PBS and plated onto 60 mm dish. The
cells were grown for 9–10 days and colonies were counted.
Analysis of chromosomal aberrations
After treatment with 0.05 mg/ml colcemid for 1 h, chromo-
somes were prepared according to the air-drying method as
described previously (22). Chromosomal aberrations were
scored according to the international nomenclature of aberra-
tions (23). Chromatid-type aberrations included gaps, breaks
and exchanges. Chromosome-type aberrations were classiﬁed
into breaks, dicentrics, rings double minutes and pulveriza-
tion. Translocations were omitted from the score because of
ambiguity in non-banded preparations. Chromatid-type gaps
were most abundantly induced by X-ray irradiation, but
were excluded from the calculation of aberrations per cell
because of ambiguity between true DNA break and aberrant
chromatin packaging. All types of aberrations were scored as
one event.
Wortmannin treatment
Cells were preincubated with 20 mM Wortmannin 3 h before
X-ray irradiation. Wortmannin treatment was maintained for
3 days after treatment.
Assessment of stable transformation
HCT116 or RAD18 /  cells were transfected with the circu-
lar or linear form of pTK-Hyg (Clontech) plasmid DNA by
electroporation and selected in the medium containing
hygromycin B (400 mg/ml) for 2 weeks. The frequency of sta-
ble transformation was assessed on the basis of the frequency
of drug-resistant colonies.
Evaluation of gene targeting at HPRT locus
The poly(A)-signalless hygromycin resistance gene was
inserted into exon 2 of HPRT in frame. A 3.1 kb 50-targeting
element was ampliﬁed from the isogenic DNA of HCT116
cells using the primer set 50-GTTGTCGACCAGGTATTAC-
GGGCCAACCTGACAATACATG-30 and 50-ATGCAAGC-
GGCCGCAAGGTCATAACCTGGTTCATCATCAC-30.A
1.8 kb 30-targeting element was ampliﬁed using the primer
set 50-TGGAAAGCGGCCGCATTCCTCATGGACTAAT-
TATGGACAGG-30 and 50-TTTATAGGCGCGCCTGAGC-
ACACAGAGGGCTACAATGTGATG-30. Ampliﬁed PCR
products were cloned into the modiﬁed pBC vector (Strata-
gene). A hygromycin resistance cassette was prepared from
pIREShygro2 (Clontech). Targeting vectors linearized with
AscI were introduced into cells by electroporation. For the
selection of targeted cells, hygromycin B was added at
400 mg/ml in the growth medium. After 14 days, colonies
were isolated and expanded. Genomic DNA from individual
colonies was screened for gene targeting by PCR using
the primer set 50-ATCAATATTGACTTCTGCCTGCTG-
TATAGC-30 and 50-GCGGCCATTGTCCGTCAGGACAT-
TGTTGGA-30.
Comet assay (single cell micro gel electrophoresis)
The alkaline comet assay was performed using a comet assay
kit (CometAssay; Trevigen) according to the manufacturer’s
protocol. DNA was stained with Cyber green. Mean tail
moment was quantiﬁed for 100 cells per sample in each
experiment using Metafer Comet Scan software.
Expression of RAD18 gene
Human RAD18 cDNA was ampliﬁed from cDNA derived
from HCT116 cells using the primer set 50-TCCGAA-
TTCGCGACCATGGACTCCCTGGCC-30 and 50-AAGGTC-
GACATTCCTATTACGCTTGTTTC-30. The cDNA was
inserted into pBC (Stratagene). RAD18 cDNA tagged with
FLAG at the C-terminus was inserted downstream of the
CMV enhancer and promoter of pCI-neo (Promega).
RAD18 /  cells were transfected by electroporation with
the RAD18 cDNA expression vector and pTK-Hyg, and
selected in the medium containing 400 mg/ml hygromycin
B (Wako, Japan) for 2 weeks. Surviving colonies were
isolated and propagated individually. The expression of the
RAD18 gene was examined by western blot analysis using
the anti-FLAG and anti-RAD18 antibodies.
RESULTS
Generation of human RAD18 /  cells
We have disrupted human RAD18 inserting a promoterless
neomycin resistant gene (neo) or poly(A)-signalless
puromycin-resistant (puro) gene into human colon carcinoma
cell line HCT116. When the targeted cell DNAs were
digested with both SpeI and KpnI, the correct insertion of
the neo or puro gene into the locus was expected to yield
a 6.6 kb or a 9.2 kb fragment, respectively, instead of
a 7.8 kb wild-type fragment (Figure 1A). G418-resistant col-
onies generated with the RAD18-neo targeting vector were
screened for targeted integration ﬁrst by PCR then by South-
ern blot analysis. Six of fourty-eight G418-resistant clones
showed the targeting bands (Figure 1B). The RAD18-puro
targeting vector was introduced into one of these clones
(RAD18
+/ ). Puromycin-resistant clones were screened for
targeted integration. Eight homozygous knockout clones
were obtained from 3000 puromycin-resistant clones. South-
ern blot analysis of one of the clones is shown in Figure 1B.
Western blot analysis revealed that no RAD18 protein was
expressed in the homozygous knockout clones and that the
level of the RAD18 protein correlated with targeting events
(Figure 1C). One homozygous knockout clone (clone 1)
was named as RAD18 /  and was used for further studies.
Growth and sensitivity of RAD18 /  cells to various
DNA-damaging agents
The growth rate of RAD18 /  cells was almost the same as
that of wild-type cells (Figure 2A). The doubling time of the
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various DNA-damaging agents was determined by colony
formation assay. As shown in Figure 2B, RAD18 /  cells
were signiﬁcantly more sensitive than wild-type HCT116 to
cisplatin, methyl methanesulfonate (MMS) or X-ray. In
contrast, surprisingly, they showed no signiﬁcant increase
in sensitivity to UV light unlike the case with RAD18-knock-
out cells from mouse ES or chicken DT40 cells, suggesting
that different mechanisms for tolerance to UV light may be
in operation in human HCT116 cells.
Chromosomal aberrations induced by X-ray irradiation
Exponentially growing wild-type HCT116 and RAD18 / 
cells were irradiated, respectively, with 1.4 Gy of X-ray,
and, at various intervals after irradiation, chromosomal
aberrations were examined in metaphase cells accumulated
by 1 h treatment with colcemid. As shown in Figure 2C,
chromosomal aberrations induced by X-ray irradiation
were mostly of the chromatid type until 10 h after irradiation.
The number of chromatid-type aberrations in HCT116
cells accumulated in metaphase within 3–4 h after irradiation
was slightly lower than or nearly the same as that in
RAD18 /  cells. These cells accumulated at metaphase
appeared to be in G2 phase at the time of irradiation judging
from the cell cycle phases determined by separate experi-
ments. The number of chromatid-type aberrations in
HCT116 cells accumulated in metaphase from 4 to 11 h
after irradiation decreased rapidly, whereas it decreased
gradually in RAD18 /  cells at the same time intervals.
These metaphase cells appeared to be in S phase at the
time of irradiation. These results indicated that DNA lesions
resulting in chromatid-type aberrations were repaired
efﬁciently during the S phase in HCT116 but not in
RAD18 /  cells, suggesting that the repair mechanism func-
tioning in the S phase was defective in RAD18 /  cells, i.e.
RAD18 was likely to have a particular repair function speciﬁc
for S phase.
Targeted integration in RAD18 /  cells
Targeted integration (gene targeting) shares the homologous
recombination (HR) repair pathway (24) with other different
types of HR (such as between sisters, between homologues).
Figure 1. Generation of RAD18 /  HCT116 cells. (A) Schematic representation of RAD18 locus, disruption constructs and configuration of targeted alleles.
Relevant restriction sites and the position of the probe used for Southern blot analysis are shown. MC1, MC1 promoter; DT-ApA, diphtheria toxin gene; puro,
puromycin resistance gene; neo, neomycin resistance gene; SRa,S R a promoter; IRES, internal ribosome entry site; pA, poly (A) additional signal. Exons 1 and
2 are indicated by numbered boxes. (B) Southern blot analysis of KpnI- and SpeI-digested genomic DNA from cells with indicated genotypes of RAD18 gene.
(C) Western blot analysis of whole-cell extracts from different HCT116 clones with indicated genotypes of RAD18 gene. G3PDH was used as an internal control.
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of the HR pathway in human cells, we have examined
targeted integration frequencies both in wild-type HCT116
and RAD18 /  cells.
To assess the frequency of targeted integration, the HPRT-
targeting vector DNA was transfected into HCT116 or
RAD18 /  cells. The frequency of targeted integration in
RAD18 /  cells was  10 times higher than that in wild-
type HCT116 cells (Table 1). These results indicated that
the loss of RAD18 function caused the increase in frequency
of targeted integration in human cells, suggesting that the
common part of the HR pathway was functioning much
more efﬁciently in RAD18 /  cells than in wild-type
HCT116 cells. Thus, RAD18 appeared to be involved in
protective function from homologous integration.
RAD18 /  cells appear normal in DSBR
In mammalian cells, DNA DSBs are mainly repaired via two
pathways, HR and nonhomologous end joining (NHEJ) path-
ways. RAD18 /  cells were signiﬁcantly hypersensitive to
radiation (Figure 2B) and were defective in the repair of chro-
mosomal aberrations (Figure 2C), suggesting that the NHEJ
pathway was not properly functioning in RAD18 /  cells.
In contrast, HR pathway in RAD18 /  cells appeared func-
tioning efﬁciently judging from their efﬁcient targeted inte-
gration activity (Table 1). Thus, next, we have attempted to
clarify whether RAD18 was involved in the NHEJ pathway.
Since stable transformation processes through random inte-
gration of an exogenous gene into host cell genome suppos-
edly need factors functioning in the NHEJ pathway (24), we
have examined random integration frequencies both in wild-
type HCT116 and RAD18 /  cells to know whether RAD18
was involved in the NHEJ pathway in human cells. For this
experiment, HCT116 and RAD18 /  cells were both
transfected with the circular or linear form of the plasmid
pTK-Hyg containing the hygromycin B resistance gene.
The frequency of stable transformation was then determined
by counting the number of the hygromycin B-resistant colon-
ies. The results obtained indicated that irrespective of plasmid
DNA forms, the transformation frequencies of RAD18 / 
cells were 6–12 times higher than those of wild-type
HCT116 cells (Table 2), suggesting that factors needed for
stable transformation appeared to be active in RAD18 / 
cells.
Wortmannin inhibits phosphatidylinositol-3 (PI-3) kinases
including its family member DNA-dependent protein kinase
(DNA-PK) involving the NHEJ pathway of DSBs. Treatment
Figure 2. Growth curves, sensitivity to DNA-damaging agents and
chromosomal aberrations induced by X-ray in RAD18 /  cells. (A) Growth
curves of wild-type (closed circles) and RAD18 /  cells (open circles). The
data show typical experimental results of three independent experiments.
(B) Sensitivities of wild-type (closed circles) and RAD18 /  cells (open
circles) to continuous treatment with cisplatin or MMS. Sensitivities to UV
light or X-ray irradiation are also shown. The data shown are means of three
independent experiments with standard deviations (error bars). (C) Chromo-
somal aberrations in HCT116 and RAD18 /  cells after X-ray irradiation.
Cells were irradiated with 1.4 Gy of X-rays and cultured thereafter. Cells
were treated with 0.05 mg/ml colcemid for 1 h prior to harvest and
chromosomes were prepared as described in Materials and Methods. A total
of 100 metaphase cells were examined in each sample. Chromatid-type
(upper) and chromosome-type (lower) aberrations in HCT116 (open circles)
and RAD18 /  (closed circles) cells were counted. Approximate cell cycle
phases (determined by separate experiments) at the time of X-ray irradiation
are shown at the top of the figure. The number of spontaneous chromatid-type
aberrations in HCT116 and RAD18 /  cells were 0.06/cell and 0.06/cell,
respectively. The number of spontaneous chromosome-type aberrations in
HCT116 and RAD18 /  cells were 0.09/cell and 0.07/cell, respectively.
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eukaryotic cells, but showed no effects on their mutant
cells defective in the NHEJ pathway such as DNA-PK
catalytic subunit (DNA-PKcs)- or XRCC4-deﬁcient cells
(25). Thus, we have examined effects of Wortmannin on
RAD18 /  cells. As shown in Figure 3A, when treated
with Wortmannin, RAD18 /  cells were sensitized to radia-
tion to the extents similar to those with HCT116 cells, indi-
cating that the functioning Wortmannin-sensitive NHEJ
pathway was present in RAD18 /  cells. The results sug-
gested that RAD18 was not directly involved in the
Wortmannin-sensitive NHEJ pathway.
RAD18 /  cells become synthetic lethal when
combined with heterozygous mutation at XRCC4
locus (XRCC4+/ )
To further investigate the functional relationship between the
RAD18-dependent strand break repair and the NHEJ path-
way, we ﬁrst attempted to disrupt one of the XRCC4 (the
gene involved in the NHEJ pathway) alleles in RAD18 / 
cells inserting the promoterless hygromycin-resistant (hyg)
gene (Supplementary Figure 1A). After transfection of
RAD18 /  cells with the targeting vector DNA, we obtained
48 hygromycin-resistant clones and subsequently examined
the targeting event by PCR analysis (Supplementary Figure
1B). This way, we have identiﬁed three candidate clones
for the heterozygous disruptant of the XRCC4 locus. Because
cells from all these three clones exhibited extremely decreased
growth rates and eventually all ceased proliferation after
forming very tiny colonies, we were unable to analyze the tar-
geting event by Southern blotting. Alternatively, we have car-
ried out nucleotide sequencing using PCR products ampliﬁed
from the genomic DNA of these three clones. Sequencing
analyses revealed that, in all the three cases, the sequence
of XRCC4 gene was fused to the hygromycin resistance
gene as expected (data not shown), indicating that these
three clones were the heterozygous disruptants of the XRCC4
locus. These results strongly suggested that RAD18 /  cells
became synthetic lethal due to the additional heterozygous
disruption of the XRCC4 locus (XRCC4+/ ). Therefore,
RAD18 may function in a repair pathway different from the
XRCC4-dependent NHEJ pathway.
RAD18 /  cells appears defective in SSBR
The major types of DNA damage resulted in chromatid-type
aberrations are DSBs and SSBs. Topoisomerase inhibitors,
CPT and etoposide (VP-16), interfere with the catalytic activ-
ity of topoisomerase I and II, and generate primarily SSBs
and DSBs, respectively (26–28). To further identify which
repair mechanism (SSBR or DSBR) was defective in
RAD18 /  cells, we examined sensitivities of HCT116
and RAD18 /  cells to these drugs. As shown in
Figure 3B and C, when compared with HCT116 cells,
RAD18 /  cells were highly sensitive to the killing effect
of CPT capable of inducing SSBs, but were slightly sensitive
to VP-16 capable of inducing DSBs. Thus, these results
strongly suggested that RAD18 /  cells were mainly defec-
tive in SSBR.
RAD18 /  cells are more sensitive to CPT than
HCT116 cells in S phase but not in non-S phase or in
non-replicating state
Exponentially growing HCT116 or RAD18 /  cells were
pulse-treated for 2 h with CPT at various concentrations.
As shown in Figure 3D, both HCT116 and RAD18 / 
cells showed the persistent presence of drug-resistant cell
populations. Thus, the cells tested could be divided into at
least two populations: one was highly sensitive to CPT
( 50% of total cells); and the other highly resistant to CPT.
When the sensitive population of RAD18 /  cells was
compared with that of HCT116, as shown in Figure 3D, the
sensitive population of RAD18 /  cells was much more
sensitive than that of HCT116 cells. On the other hand, the
resistant population of RAD18 /  cells was as resistant as
that of HCT116 cells (Figure 3D). These results suggested
the possibilities that the sensitivity to CPT could be depen-
dent on cell cycle phases, and that RAD18 /  cells were
highly sensitive to CPT only in a certain cell cycle phase(s).
To identify the possible sensitive phase(s) in the cell cycle,
we have synchronized the cells followed by pulse treatment
with CPT, and examined the sensitivities. As shown in
Figure 3E, both HCT116 and RAD18 /  cells in the G2
Table 1. Frequency of targeted integration
a
Expt no. No. of colonies with targeted integration/total
no. tested
HCT116 (W.T.) RAD18 / 
1 0/280 10/316
2 2/258 10/203
3 1/442 21/587
Total (%) 3/980 (0.31) 41/1106 (3.71)
aTheHPRTallele-targetingconstructwastransfectedintocells.Afterselection
with 400 mg/ml of hygromycin, targeted integration events were determined
by PCR.
Table 2. Frequency of stable transformation
Expt no. Cells Plasmid DNA (
bCo r
cL) No. of cells plated Plating efficiency No. of cells tested No. of hygro
r clones
aS.T. frequency
1 HCT116 pTK-hygro (C) 2 · 10
6 0.63 1.27 · 10
6 8 6.3 · 10
 6
HCT116 pTK-hygro (L) 2 · 10
6 0.64 1.28 · 10
6 11 8.6 · 10
 6
RAD18 /  pTK-hygro (C) 2 · 10
6 0.51 1.01 · 10
6 39 38.6 · 10
 6
RAD18 /  pTK-hygro (L) 2 · 10
6 0.43 0.86 · 10
6 42 49.0 · 10
 6
2 HCT116 pTK-hygro (C) 2 · 10
6 0.60 1.20 · 10
6 10 8.3 · 10
 6
HCT116 pTK-hygro (L) 2 · 10
6 0.74 1.47 · 10
6 10 6.8 · 10
 6
RAD18 /  pTK-hygro (C) 2 · 10
6 0.41 0.82 · 10
6 74 90.6 · 10
 6
RAD18 /  pTK-hygro (L) 2 · 10
6 0.43 0.85 · 10
6 70 82.4 · 10
 6
aST, stable transformation;
bC, circular;
cL, linear.
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treatment on the survival of HCT116 (gray bars) and RAD18 /  cells (closed bars). Cells were irradiated with 1 Gy of X-rays. Cells were preincubated with
20 mM Wortmannin for 3 h before irradiation and Wortmannin treatment was maintained after irradiation. (B and C) Survival curves for HCT116 (open circles)
and RAD18 /  (closed circles) cells after continuous culture with indicated concentrations of VP-16 (B) or CPT (C). (D) Survival curves for exponentially
growing HCT116 (open triangles) and RAD18 /  (closed triangles) cells treated for 2 h with indicated concentrations of CPT. (E) Survival curves for HCT116
(open circles and open squares) and RAD18 /  (closed circles and closed squares) cells synchronized at S phase (open circles and closed circles) or G2 phase
(open squares and closed squares) and treated for 2 h with indicated doses of CPT. (F) Survival curves for HCT116 (open circles) and RAD18 /  (closed
circles) cells treated for 2 h with CPT (up to 100 nM) and APH as described in Materials and Methods. (G) Broadening of low-dose range shown in (F) up to
1000 nM of CPT. (H) Strand breaks quantified in S phase cells untreated or treated with CPT (100 nM for 30 min) and then incubated for 0, 60 or 120 min in
drug-free medium. S phase cells were prepared as described in Materials and Methods. (I) Strand breaks quantified in mock-treated or CPT-treated (2000 nM for
30 min) cells with APH (1 mg/ml) and incubated for 0, 30 or 60 min in CPT-free medium containing APH (1 mg/ml). Data shown are means of three independent
experiments with standard deviations (error bars).
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lines in the S phase were highly sensitive to CPT, though
RAD18 /  cells were much more sensitive than HCT116
cells (Figure 3E), suggesting that RAD18 was involved in
the SSBR mechanism in the S phase, i.e. the mechanism
underlying the tolerance to the toxic effect of CPT.
To determine whether the sensitivity of RAD18 /  cells
to CPT depends on DNA synthesis, we have examined CPT
sensitivity in the presence of a DNA replication inhibitor
APH. In the absence of DNA replication by treatment with
APH, those cells in S phase showed perfect resistance to
CPT (Figure 3F), implying that replicative DNA synthesis
was necessary for the manifestation of CPT sensitivity. Fur-
ther, as shown in Figure 3G, when both cell lines were treated
with much higher doses of CPT in the presence of APH,
>50% of both cells survived even after 1000 nM CPT treat-
ment, although surviving fractions in both cell lines gradually
decreased. These results implied that CPT-induced SSBs
were removed at the same efﬁciency in both cell lines in
the non-replicating state, even in the S phase.
SSBR in RAD18 /  cells is defective when examined
by alkaline comet assay
To clarify the molecular basis of CPT hypersensitivity in
RAD18 /  cells, the level of DNA strand breaks induced
by CPT was determined by alkaline comet assay (alkaline
single cell micro gel electrophoresis), and was compared
between HCT116 and RAD18 /  cells. In both cell lines
synchronized in the S phase, the same levels of strand breaks
accumulated following the 30 min treatment with CPT. In
HCT116 cells, CPT-induced strand breaks were repaired
almost completely during 120 min repair period, whereas
signiﬁcant levels of induced breaks persisted in RAD18 / 
cells even at 120 min period (Figure 3H), indicating that
RAD18 /  cells were defective in strand break repair
when cells were in the S phase. However, in non-replicating
cells whose replication was inhibited by APH-treatment,
strand breaks were repaired as efﬁciently in RAD18 cells as
in HCT116 cells (Figure 3I), indicating that strand breaks
were repaired normally in both cells in the non-replicating
state. It should be pointed out that, although both SSBs and
DSBs can be detected by alkaline comet assay, most of the
CPT-induced strand breaks detected were SSBs (29). Thus,
RAD18 /  cells were defective in SSBR in the S phase, par-
ticularly under the replication-ongoing state, implying that
RAD18 has particular function in S phase for SSBR.
RAD18-dependent strand break repair does not require
monoubiquitination of PCNA
At stalled replication forks caused by UV-induced lesions,
PCNA has been shown to be monoubiquitinated in
a RAD18-dependent manner in mammalian cells as well as
in yeast cells, and this monoubiquitination subsequently
caused a polymerase switch from replicative polymerase to
translesion polymerase in TLS (12,13). PCNA has also
been reported to be monoubiquitinated after the treatment
of human cells with hydroxyurea (HU), which caused replica-
tion fork stalling, suggesting that such modiﬁcation of PCNA
could have been induced by the blockade of replication forks
(12). Thus, we have examined the monoubiquitination of
PCNA after treatment with UV or HU in RAD18 / 
human cells.
As shown in Figure 4A, the monoubiquitination of PCNA
was observed when HCT116 cells were irradiated with UV
light or cultured in the medium containing 1 mM HU. How-
ever, monoubiquitination was not observed in RAD18 / 
cells, indicating that human RAD18 played a critical role in
the monoubiquitination of PCNA following UV light irradia-
tion or HU treatment, as reported previously (12,13).
As described above, RAD18 /  cells were moderately
sensitive to X-ray irradiation or VP-16 treatment, and were
highly sensitive to CPT treatment (Figures 2B, 3B and C).
Thus, next, we have examined whether these treatments
could also induce the monoubiquitination of PCNA. Treat-
ment of RAD18 /  cells with CPT or VP-16, or X-ray irra-
diation did not induce the monoubiquitination of PCNA for
up to 24 h (Figure 4B). Similar observation was made even
in wild-type HCT116 cells (Figure 4B), although the
monoubiquitination of PCNA was detected 5 h after UV
light irradiation. These results strongly suggested that
PCNA monoubiquitination was not required for the repair
of strand breaks resulting from treatment with CPT or VP-
16, or X-ray irradiation.
Ectopical overexpression of RAD18 cDNA
complements defective monoubiquitination of PCNA
and hypersensitivity to CPT in RAD18 /  cells
To conﬁrm whether both the failure of PCNA monoubiquiti-
nation after UV light irradiation and the hypersensitivity to
CPT in RAD18 /  cells were due to the defect of
RAD18, we have established several RAD18 /  cell clones
ectopically expressing wild-type human RAD18. In this
Figure 4. Monoubiquitination of PCNA. (A) UV light- or HU-induced
monoubiquitination of PCNA as determined by western blot analysis. Wild-
type HCT116 or RAD18 /  cells were irradiated with 20 J/m
2 of UV light or
cultured in the presence of 1 mM HU and harvested at indicated times.
(B) Monoubiquitination of PCNA after treatment with UV light, X-ray,
VP-16 or CPT. HCT116 or RAD18 /  cells were irradiated with UV light
(20 J/m
2) or X-rays (5 Gy) and harvested after 5 or 24 h incubation for
western blot analysis. Cells were cultured in the medium containing CPT
(5 or 25 nM) or VP-16 (0.6 or 3 mM) and harvested at indicated times.
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the plasmid pTK-Hyg and the RAD18 cDNA expression
vector, in which RAD18 was tagged with FLAG to distin-
guish the introduced RAD18 from the endogenous RAD18
that might be produced by the reversion or alternative
splicing of the target-disrupted RAD18 gene.
First, we selected hygromycin-resistant clones and then
screened these drug-resistant clones by PCR analysis to
identify clones stably integrating the full-length RAD18
cDNA. PCR-positive clones (clone nos 5, 15, 28, 38, 41, 44
and 45) were examined by western blot analysis using anti-
FLAG and anti-RAD18 antibodies as probes. As shown in
Figure 5A, clones 15, 28 and 41 expressed the RAD18 pro-
tein. In clone 28, PCNA was ubiquitinated at the same
level as that in HCT116 cells after UV irradiation, but in
clone 41, PCNA ubiquitination was very weak even after
UV irradiation (Figure 5B). In non-expressing clones (clones
5 and 38), any ubiquitinated PCNA was not detected even
after UV irradiation (Figure 5B).
As shown in Figure 5C, either clone 5 or 38, into whose
genome the full-length RAD18 cDNA had been integrated,
respectively, did not express the RAD18 protein
(Figure 5A), and was as sensitive to CPT as RAD18 / 
cells. On the other hand, clones 28 and 41 both expressing
the RAD18 protein were signiﬁcantly more resistant to CPT
than RAD18 /  cells, although still less resistant than
HCT116 cells (Figure 5C). The intermediate resistance of
clones 28 and 41 to CPT and the incomplete monoubiquitina-
tion of PCNA in clone 41 could be explained by the disrup-
tive effect of FLAG on RAD18. These results described
above indicated that high sensitivity to CPT and the defective
monoubiquitination of PCNA after UV irradiation in
RAD18 /  cells were caused by a defect of RAD18.
DISCUSSION
RAD18 is involved in the repair of X-ray-induced DNA
damage independent of PCNA monoubiquitination
Recently, it was reported that PCNA was monoubiquitinated
in a RAD18/RAD6-dependent manner at replication forks
stalled by UV light-induced lesions in human and mouse
cells as well as in yeast, and the monoubiquitination of
PCNA caused a polymerase switch from a replicative to
a translesion polymerase in TLS (12,13). RAD18 gene dis-
ruption in either yeast, chicken or mouse cells resulted in
sensitivity to various DNA-damaging agents due probably
to the lack of the polymerase switch. Thus, the mechanism
underlying polymerase switching through the monoubiquiti-
nation of PCNA appears to be conserved in a variety of
species.
As shown in Figure 2B, RAD18-knockout (RAD18 / )
cells generated from human HCT116 cells were signiﬁcantly
hypersensitive to X-ray irradiation (Figure 2B) and defective
in the repair of X-ray-induced chromosomal aberrations
(Figure 3C) when compared with wild-type HCT116 cells.
However, X-irradiation, unlike UV irradiation, did not cause
PCNA monoubiquitination in HCT116 cells (Figure 4B).
These ﬁndings strongly suggested that, upon X-ray-induced
DNA damage such as DNA strand breaks (DSBs and/or
SSBs), RAD18 was involved in some other repair mecha-
nisms independent of PCNA monoubiquitination.
RAD18 functions in repair pathway different from both
HR and NHEJ pathways of DSBR
Forms of DNA damage that results in chromatid-type
aberrations are DSBs and SSBs. As shown in Figure 3C,
Figure 5. Restoration of CPT sensitivity and UV-induced PCNA monoubiquitination in RAD18 /  cells expressing FLAG-tagged human RAD18.
(A) Detection of FLAG-tagged RAD18 using anti-FLAG antibody or anti-human RAD18 antibody. Seven hygromycin-resistant clones (clones 5, 15, 28, 38, 41,
44 and 45) were examined for the expression of the FLAG-tagged RAD18 by western blot analysis. (B) Restoration of UV light-induced monoubiquitination of
PCNA in clones (clones 28 and 41) expressing FLAG-tagged RAD18, but not in non-expressing clones (clones 5 and 38). (C) Restoration of CPT sensitivity in
clones expressing FLAG-tagged RAD18 (clones 28 and 48), but not in non-expressing clones (clones 5 and 38) as determined by colony-forming assay.
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(DSBs and/or SSBs) efﬁciently in the S phase but RAD18 / 
cells have not, indicating that some strand break repair
mechanism functioning in the S phase could have been defec-
tive in RAD18 /  cells. In mammalian cells, DSBs are
mainly repaired through two major repair pathways, HR
and NHEJ. RAD18 /  cells appeared to have functioning
HR pathway because of their efﬁcient homologous integra-
tion activity (Table 1) and also to have functioning NHEJ
pathway since they showed efﬁcient stable transformation
activity (Table 2) and since a NHEJ inhibitor, Wortmannin,
increased the radiation sensitivity of RAD18 /  cells to
extents similar to that of HCT116 cells (Figure 3A), indicat-
ing that the Wortmannin-sensitive NHEJ pathway is working
normally in RAD18 /  cells.
The synthetic lethality of RAD18- and RAD54-double
knockout cells has been reported in chicken DT40 cells
(19). Either of these single knockouts caused only a slight
phenotypic change in terms of cell proliferation. Single
knockout of most genes involved in HR caused a severe
phenotype such as hypersensitivity to ionizing radiation,
severe growth retardation or cellular lethality, whereas
knockout of the RAD54 gene among genes involved in HR
caused a relatively mild phenotype such as slight sensitivity
to ionizing radiation and a normal cell growth rate in both
murine embryonic stem cells and DT40 cells (30,31).
Furthermore, in our present study, we found the synthetic
lethality of RAD18-knockout mutation in human HCT116
cells when the gene knockout was combined with the het-
erozygous disruption (+/ ) of the NHEJ repair gene
XRCC4. HCT116 cells with the heterozygous disruption of
XRCC4 showed heteroinsufﬁciency, i.e. a slow cell growth
rate and a slight sensitivity to ionizing radiation (M. Mori,
unpublished data). Thus, when the minor defect in NHEJ
caused by heterozygous disruption of XRCC4 was combined
with RAD18-knockout, the resultant cells exhibited synthetic
lethality as was observed in the cells with double knockouts
of both RAD18 and RAD54 genes. As mentioned above,
RAD54 is involved in HR repair whereas XRCC4 is in
NHEJ repair. Thus, these synergistic phenotypes observed
in double knockout cells indicate that a RAD18-dependent
repair mechanism functions in a pathway different from
both RAD54-dependent HR and XRCC4-dependent NHEJ
pathways of DSBR.
RAD18 is involved in SSBR in S phase
A topoisomerase (Top 1) inhibitor CPT interferes with the
catalytic cycle of Top 1 by stabilizing the covalent complex,
called cleavage complex, formed between Top 1 and cleaved
DNA (27). Cleavage complexes are repaired: ﬁrst, tyrosyl
phosphodiesterase1 (TDP1) cuts Top 1-DNA cross-links;
and then resulting SSBs are repaired by XRCC1-dependent
SSBR mechanisms (29,32). Because RAD18 /  cells were
hypersensitive to CPT when compared with wild-type
HCT116 cells (Figure 3C), RAD18 appeared to be involved
in some step(s) of the repair mechanism for the cleavage
complex.
The inherited disorder spinocerebellar ataxia with axonal
neuropathy-1 (SCAN1) was caused by a mutation in TDP1
(33). SCAN 1 cells were reported to be defective in the repair
of CPT-induced Top 1-DNA cross-links and SSBs, and
highly sensitive to CPT when compared with wild-type
cells (29,34). Furthermore, EM9 Chinese hamster ovary
cells lacking XRCC1, a central factor for SSBR, were also
hypersensitive to CPT, but not to VP-16 (35). On the other
hand, Chinese hamster ovary mutant xrs1 (Ku80-deﬁcient
mutant) cells were defective in DSBR and highly sensitive
to VP-16, but not to CPT when compared with wild-type
cells (36). These ﬁndings imply that DNA damage induced
by CPT is mainly repaired by SSBR.
As shown in Figure 3D–G, RAD18 /  cells were hyper-
sensitive to CPT only in the S phase when replicative
DNA synthesis was ongoing, whereas they were not sensitive
in other phases of cell cycle or in the S phase when replica-
tive DNA synthesis was inhibited. Thus, function of
RAD18 appears to be tightly associated with SSBR on
replication-ongoing sites. Indeed, in RAD18 /  cells,
X-ray-induced SSBs appeared to be not repaired efﬁciently
and resulted in chromatid-type aberrations via DNA replica-
tion (Figure 2C). Furthermore, the defective SSBR in the
S phase was conﬁrmed by the alkaline comet assay in
RAD18 /  cells (Figure 3H and I). These ﬁndings strongly
suggest that RAD18 plays an important role in the S-phase-
speciﬁc SSBR process that still remains unresolved.
It has been reported that XRCC1-deﬁcient Chinese hamster
mutant EM9 cells showed higher sensitivity to CPT in the
S phase than did wild-type AA8 cells. EM9 cells were also
highly sensitivity to CPT in the non-S phase or non-
replicating state when compared with AA8 cells (37). Fur-
thermore, TDP1-deﬁcient human SCAN1 cells have been
reported to be deﬁcient in their ability to repair SSBs caused
by CPT both in the S phase and in the non-S phase (29,34).
These ﬁndings indicate that if cells are deﬁcient in factors
functioning in the general repair pathways for SSBs, then
the cells are sensitive to CPT throughout the cell cycle,
which is different from our present ﬁnding that RAD18
involved the S phase-speciﬁc repair function.
Because SSBs are converted to more severe secondary
damage, i.e. DSBs, via replication (38) when SSBs are gener-
ated in the S phase or when unrepaired SSBs are persisting in
the S phase, cells need to remove SSBs as rapidly as possible
before SSBs are converted into DSBs to avoid the toxic effect
of such damage. To facilitate SSBR in the S phase, RAD18
may function in the S phase-speciﬁc SSBR pathway
(RAD18-dependent SSBR).
Although SSBR functions efﬁciently in the S phase, SSBs
may have already been converted into DSBs. In such a situa-
tion, the HR and NHEJ pathways could serve as backup
repair pathways for removing generated DSBs; thereby,
cells can escape from the toxic effect of such DNA damage.
As mentioned above, double mutant cells defective in both
RAD18 and a gene functioning in HR or NHEJ were synthetic
lethal. In these double knockout cells, SSBR in the S phase
alone may be insufﬁcient, since unrepaired SSBs could be
converted into DSBs more frequently than in normal cells.
DSBs are fatal for mutant cells deﬁcient in the DSBR path-
way, even though the DSBR deﬁciency is marginal (as in
XRCC4+/ ). Thus, the double knockout cells are likely to
show such a lethal phenotype.
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S phase-specific SSBR?
RAD18 has been shown to accumulate quite rapidly at the
site of SSBs independent of DNA replication and also inde-
pendent of accumulation of the general SSBR proteins
PARP and XRCC1 (39). In the non-S phase, SSBs are
repaired efﬁciently through the rapid XRCC1-dependent
SSBR pathway irrespective of the existence of RAD18,
because RAD18 /  cells in the non-S phase were as resis-
tant to CPT as wild-type HCT116 cells (Figure 3D–G). On
the other hand, in the S phase, RAD18-dependent SSBR
could be the one working. During DNA replication, a replica-
tion fork encounters an unrepaired SSB to which RAD18 is
already bound, and this may serve as a signal for the activa-
tion (or initiation) of RAD18-dependent SSBR.
RAD18 is known as a ubiquitin ligase. PCNA was
monoubiquitinated in a RAD18- dependent manner in
cooperation with RAD6 (a ubiquitin-conjugating enzyme) at
replication forks stalled by DNA lesions, and the monoubiq-
uitination of PCNA caused a polymerase switch from
a replicative to a translesion polymerase in TLS (12,13). In
S phase-speciﬁc SSBR, RAD18 could ubiquitinate some
protein other than PCNA in cooperation with RAD6 at
SSBs, thereby stimulating the activity of SSBR. Further bio-
chemical analysis is required to determine the role of RAD18
in the S phase-speciﬁc SSBR pathway in human cells. Our
RAD18 /  cells could serve as a useful tool for such studies.
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